Digital Health Startups
6,443 companies tagged Digital Health, with their investors and founders.
Amissa Health quantifies symptoms through wearable data and biometric collection to improve clinical care and research, with a focus on early detection of Alzheimer's and digital biomarkers for perimenopause in women. The company serves healthcare institutions, researchers, and patients seeking personalized treatment guidance.
2 investors
AmplifiDx develops point-of-care molecular diagnostic tests and its DX 100 platform for family, women's, and sexual health, targeting infectious disease detection for healthcare professionals and patients. The multiplex platform can detect up to 10 analytes with rapid results and minimal hands-on time.
2 investors
Amplifier Health provides a Voice Intelligence API that extracts over 1,000 acoustic biomarkers from a single voice sample to enable non-invasive health screening and turn any microphone into a clinical diagnostic tool. It serves healthcare and research partners for voice-based condition detection.
2 investors
AnchorDx (εΊεε»η) develops ctDNA methylation high-throughput sequencing technology for early cancer detection, using blood and urine samples to cover more than 70% of high-incidence cancers including lung, breast, digestive-system and urinary-system cancers. Its products span cancer early screening, early diagnosis, recurrence monitoring, and companion diagnostics.
2 investors
Andel is a cooperative pharmacy marketplace that gives employer health plans access to manufacturer-direct pricing on high-cost medications, cutting out rebates and middlemen. It manages the full pharmacy experience β intake, fulfillment, and delivery β and offers an API for real-time plan integration, serving plan sponsors and their members.
2 investors
AndHealth provides comprehensive chronic care with evidence-based treatments to reduce symptoms and flares and slow disease progression, offering virtual or in-person appointments. Its care team includes board-certified specialists covering dermatology conditions (psoriasis, psoriatic arthritis, atopic dermatitis, hidradenitis suppurativa), multiple sclerosis, HIV and Hepatitis C, along with whole-health providers, pharmacists, and health coaches.
2 investors
Angels of Care provides in-home health care, matching families with nurses, therapists, attendants, CNAs, and specialists to care for their loved ones. It operates across multiple U.S. states.
2 investors
Ankr provides patient care coordination and communication services that deliver clinical results same-day and enable direct doctor-patient communication outside standard clinic hours. The platform is designed for patients seeking streamlined healthcare interactions without repetitive form-filling.
2 investors
ANNA Autism Care provides ABA therapy for autistic children using Naturalistic Developmental Behavioral Intervention alongside parent coaching. It offers intervention services and insurance support, accepting most major insurance providers including Medicaid.
2 investors
Annette is a subscription weight-loss coaching program that combines nutritional, behavioral, and physical-activity support with an app, dietitians available by chat, and referral to independent physicians who can evaluate eligibility for GLP-1 obesity treatments. It serves individuals seeking sustainable weight loss with or without medical treatment, primarily in France.
2 investors
Annexus Health provides tech-enabled software and services, including its AssistPoint platform, that help healthcare organizations, infusion centers, specialty pharmacies, life science companies, and charitable foundations connect patients with financial assistance and access resources. Its tools automate patient assistance enrollment to reduce administrative burden and improve access to therapy and revenue capture for providers.
2 investors
Antara Health is a virtual-first primary care provider offering health navigation services, including virtual doctor consultations, mental health and nutrition support, medication delivery, health screening, and chronic condition management. It serves companies and their employees to improve workforce health in Kenya.
2 investors
Anto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.
2 investors
Apnimed develops investigational oral pharmaceutical therapies for obstructive sleep apnea (OSA), including its lead clinical candidate AD109, a neuromuscular approach intended to treat undertreated and untreated OSA patients. It is a clinical-stage pharmaceutical company focused on sleep apnea.
2 investors
Appa provides a technology-based mentorship program that pairs teens with vetted, trained mentors and an evidence-based curriculum to build motivation, confidence, and resilience. It serves K-12 schools, districts, and counties, with a focus on reaching underserved and diverse student communities.
2 investors
Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases. The company leverages scientific expertise and infrastructure to advance novel therapeutics through preclinical and clinical development.
2 investors
April Health provides a turnkey Collaborative Care Management program that lets primary and specialty care practices offer and bill for behavioral health support. It combines masters-level mental health professionals, consulting psychiatrists, EHR-integrated referral software, and Wysa's therapy coaching app to treat patients with anxiety, depression, and other mental health issues.
2 investors
AptsciAptamer Science develops aptamer-based drug delivery and diagnostic platforms for precision medicine applications. The company specializes in cancer therapeutics using its proprietary ApDC (Aptamer-Drug Conjugate) technology, as well as early-stage lung cancer diagnostic kits and emerging programs in immunotherapy and metabolic disease.
2 investors
Aradigm develops financial and delivery infrastructure for cell and gene therapies, partnering with payers, providers, manufacturers, and patients to enable sustainable access to transformative treatments through a pass-through business model.
2 investors
Arbital Health provides a platform for managing value-based care (VBC) contracts, unifying claims, utilization, benchmark, and contract data with actuarial tools, predictive models, and a conversational "Actuarial AI" for real-time performance monitoring and risk analysis. It serves healthcare organizations and value-based care teams, pairing its software with dedicated VBC actuary expertise.
2 investors
ArcDia International develops and manufactures in vitro diagnostic solutions for acute infections such as COVID-19, influenza, RSV, and CDI, enabling rapid decentralized testing in hospitals, healthcare centers, and workplaces. The company also offers mariAST for antimicrobial susceptibility testing and mariCloud for real-time epidemiological surveillance.
2 investors
Arena Labs provides digital coaching, educational curriculum, and physiological data tools designed for healthcare professionals. The platform delivers on-demand performance coaching and video-based training from experts to support high-stress medical work.
2 investors
Arkangel AI provides an AI platform that reviews medical charts to identify documentation gaps, coding errors, and missed billable services, supporting ICD-10/CPT coding, compliance validation, clinical risk flagging, and clinical trial eligibility. It serves healthcare professionals and organizations ranging from solo practitioners to enterprise health systems.
2 investors
Arkos Health provides value-based care solutions that combine technology with in-home, virtual, and in-clinic care to connect payers, provider organizations, and patients. It operates as both a network provider and management partner to help transform fee-for-service networks into integrated value-based care delivery systems.
2 investors